- Lobbying
- Lobbying by Pfizer, Inc.
Lobbying Relationship
Bills mentioned
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Sudafi Henry | Legislative Director for Rep. Major Owens; Legislative Director for Rep. Emanuel Cleaver; Counsel & Sr. Policy Advisor for Rep. Steny Hoyer; Asst. and Dir. of Legislative Affairs for VP Joe Biden |
Eriade Williams | Deputy Chief of Staff/Legis. Dir., Rep Brady; Sr. Policy Adviser/Counsel, Rep. Brady; Legis. Assistant, Rep. Brady; Press Secretary, Rep. Wynn; Intern, Rep. Wynn |
Kwabena Nsiah | Rep. Frank, Intern; Rep. Israel, Staff Assistant; Rep. Becerra, Legis. Correspondent/Legis. Aide, Legis. Assistant; House Democratic Caucus, Policy Advisor; Joint Economic Committee, Sr. Policy Advisor Congressional Black Caucus, Policy Director; Rep. Richmond, Chief of Staff |
Estefania Rodriguez | Chief of Staff, May 2021-July 2022; Legis. Dir., January 2021-May 2021, Rep. Bourdeaux; Policy Dir., April 2019-December 2021, Congressional Hispanic Caucus; Sr. Legis. Assistant, September 2018-April 2020, Rep. Johnson Sr. Legis. Assistant, November 2017-September 2018, Rep. Barragan. |
Saul Hernandez | Special Assistant-Rep. Frank W. Ballance, Jr.; Special Assistant, Systems Admin., Legislative Correspondent, Deputy Press Secretary, Legislative Assistant, Legislative Director, Deputy Chief of Staff and Acting Chief of Staff-Rep. G.K. Butterfield |
Joseph Kwabena Nsiah | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Office of Management & Budget (OMB)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Office of Management & Budget (OMB)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Office of Management & Budget (OMB)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Office of Management & Budget (OMB)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Office of Management & Budget (OMB)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: General health care policy and biopharmaceutical manufacturing issues..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate